Copolymers and methods of treating prion-related diseases
OwnerNeil R. Cashman, Marc Pinard +1inventors
InventorsNeil R. Cashman, Marc Pinard, Harry Ledebur JR.
Life of this patent
Estimating the term…
Abstract
The use of a pharmaceutical composition comprising a peptide copolymer of lysine and tyrosine (e.g. copaxone) in combatting prion-related diseases is described.
Claims27
A pharmaceutical composition that inhibits binding of prion protein to a cell surface or combats a prion-related disease comprising a positively charged copolymer including a basic amino acid selected from the group consisting of lysine and arginine in association with a pharmaceutically acceptable diluent or carrier.
A pharmaceutical kit for combatting a prion-related disease comprising a positively charged copolymer including a basic amino acid selected from the group consisting of lysine and arginine, a pharmaceutically acceptable diluent or carrier and instructions for use in combatting said disease.
18 A kit according to claim 14 wherein said copolymer comprises copaxone.
Dependencies are inferred from the claim text.